Advancing RAS inhibition: broad-spectrum targeting and tumor-selective activity of RMC-7977 in cancer therapy
Crossref DOI link: https://doi.org/10.1007/s11427-024-2669-2
Published Online: 2024-10-21
Published Print: 2025-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xiong, Qunli
Zhang, Yaguang
Text and Data Mining valid from 2024-10-21
Version of Record valid from 2024-10-21
Article History
Received: 23 April 2024
Accepted: 26 June 2024
First Online: 21 October 2024
Compliance and ethics
: The authors declare that they have no conflict of Interest.